HCPCS Level IIdrugActive
J2427
Inj, invega hafyera/trinza
BETOS: O1E
Effective: 2023-07-01
Description
Injection, paliperidone palmitate extended release (invega hafyera, or invega trinza), 1 mg
Medicare Part B Drug Pricing
Average Sales Price (ASP) data for Q1 2026
Drug Name
Invega Trinza
Manufacturer
Janssen Pharmaceuticals, Inc.
HCPCS Dosage
1MG
Billing Units
273.0000
6
NDC Products
asp
Pricing Source
Medicare Part B drugs are reimbursed at ASP + 6%. Pricing updates quarterly based on manufacturer-reported data.